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Predictors of Breast Density in Hispanic and Latino Women Living in the
Northeast Region of the United States

Emma Claye

Abstract
Introduction: Breast density, the fibroglandular, non-fatty tissue in the breast, has been shown to be a
significant risk factor for breast cancer. Little is currently known about the predictors of breast density among
the understudied but increasing population of Hispanic and Latino women in the United States.
Objectives: The objective of this study is to identify predictors of breast density among Hispanic and Latino
women in Connecticut and to determine if these differ from those described in other populations. Because the
hormonal milieu is somewhat different in Hispanic/Latinas compared with White women, we are interested in
how these variables impact breast density. We are primarily interested in the role of reproductive and
physiological factors.
Methods: We analyzed for breast density predictors in an established cohort of 1,600 Hispanic and Latino
women recruited from primary care clinics in Connecticut. Baseline interview questions provided prospective
data on biological, medical care, and sociodemographic factors. Subjects provided informed consent for the
retrieval of mammography reports from screening facilities during the follow-up period. These reports
provided breast density information based on radiologist assigned BI-RADS classification. Associations
between predictors and breast density were examined with descriptive statistics and chi square statistical tests
for which p-values were reported. We additionally calculated odds ratios and 95% confidence intervals using
logistic regression modeling.
Results: Breast density data were collected for 1,040 women (65.4%). 280 women (27%) were identified as
having dense breasts while 760 women (73%) were classified as having nondense breasts based on screening
mammogram reports. In the multivariate model, breast density predictors were generally consistent with those
reported in previous studies. Additionally, we found women with diabetes to be at significantly reduced odds
of breast density. There was also evidence that the relationship between age at menarche and density was
modified by BMI.
Conclusion: Our findings suggest that Hispanic and Latino women differ in breast density distribution relative
to the general population. Additionally, we observed the protective effect of diabetes and potential interaction
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between age at menarche and BMI. This investigation enhances our understanding of breast density in
Hispanic and Latino women and provides the basis for further research and inquiry within this population.
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Introduction
Breast cancer is the most common form of cancer among women in the United States and the
second leading cause of cancer mortality among Americans (1, 2). In 2016, an estimated 246,660 cases
and more than 40,000 deaths from breast cancer are projected in the United States (3). Among Hispanic
and Latino women, breast cancer incidence is lower when compared to White and Black women, yet it is
the most common cause of cancer mortality in this population (3, 4).
Breast density, referring to the fibroglandular, non-fatty tissue in the breast, is known to be one of
the strongest predictors of breast cancer incidence (5, 6). Studies show a minimum three to four fold
increase in breast cancer risk among women with dense breasts relative to women without dense breasts
(6-8). Meta-analyses performed by McCormack and Silva show consistent findings across 42 studies of
the significant association between density and breast cancer (5). Research also suggests a protective
effect of fatty, nondense tissue against the development of cancer (9, 10).
Because of its association with higher risk of breast cancer and lowered sensitivity of screening
mammograms, breast density is required by law in several states, including Connecticut, to be routinely
disclosed on mammography reports. Density is assessed on screening mammograms through the Breast
Imaging Reporting and Data System (BI-RADS) created by the American College of Radiology to
categorize breast density (11). BI-RADS reflects a subjective assessment and categorization of the
proportion of dense tissue relative to fatty tissue in the breast. Radiologists will classify the breast tissue
into one of four categories: predominantly fatty, scattered fibrogladular densities, heterogeneously dense,
and extremely dense (11).
Although numerous studies have been performed with regard to breast density in White and
Black women, Hispanic and Latino women living in the United States remain understudied (12). To our
knowledge, there is only one published study that has addressed breast density in Hispanic and Latino
women living in the Northeast region of the United States, however the sample size of this group was
small (n=81) and Hispanic and Latino women were not the primary focus of the study (13). Cross
sectional studies have provided some insight regarding the association between breast density and breast
1

cancer risk factors (such as age, menopause status, weight, and hormone replacement therapy) in this
population (14). Others have included Hispanic and Latino women in their analyses but examined specific
associations with dietary factors and body composition (12, 15). A number of previous studies
additionally give sole focus to women of Mexican ancestry (16-19).
In the United States, the Hispanic and Latino population are the largest non-majority group, with
their numbers expected to grow over the next several decades (20). Given increases in the population size
of this group and cultural, demographic, and ancestral differences among Hispanic and Latino women
living in the northeast, there are significant public health implications associated with the identification of
the risk factors of breast density in this population, such as educational awareness and necessary access
healthcare resources. In this exploratory analysis, we aim to report the distribution of breast density in
Hispanic and Latino women living in four residential enclaves of Connecticut and identify significant
biological, reproductive, and sociodemographic predictors of breast density in the population.

Materials and Methods
Data Sources
Data were collected as part of a larger prospective cohort study, Cancer Screening in Hispanic/
Latinas Living in the Northeast, U.S. (RO1CA134276, Beth A. Jones, PI). The main objectives of this
study were to examine predictors of mammographic screening behavior and adherence to screening
guidelines during a 2.5 to 4 year follow-up period. Eligible participants were recruited from one of eleven
participating primary care facilities in Waterbury, New Haven, Hartford, and Bridgeport, four of the
largest enclaves for Hispanic and Latino populations in Connecticut according to U.S. Census Bureau
data (21). Working within these facilities at different times and days of the week, our bilingual, bicultural
research staff recruited women who self-identified as Hispanic or Latino and met the eligibility criteria
for this study. Of the nearly 1,600 women (n=1,591 remained in the final data set) who provided baseline
data, 98% provided written consent allowing investigators to access and review mammography reports
and all relevant correspondence with regard to the mammogram results. Bilingual research staff
conducted hour-long interviews with study subjects via telephone. We collected extensive information of
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sociodemographic, medical history, acculturation, sociocultural, and mammography screening data, as
well as known predictors of breast density and established breast cancer risk factors. We accessed
mammographic radiology reports and images for 1,569 women from facilities identified by the
respondent as a place she had received mammography in the past, would seek a mammogram in the
future, or from all mammography facilities in the city in which she was recruited. Although it is not a
closed system, there is a relatively low number of large facilities that provide all mammography services
in these urban areas. All activities in this study were approved by the Yale Human Investigation
Committee, in addition to all research oversight committees at participating facilities.
Study Population
We targeted the four cities in Connecticut with the largest Hispanic/Latino populations
(Waterbury, New Haven, Hartford, and Bridgeport). Our study sample includes Hispanic and Latino
women who presented at participating primary care clinics (hospital based and Federally Qualified Health
Centers [FHQCs]) in these areas and who were between the ages of 40-75 at the time of enrollment.
Additional eligibility criteria included that participants have no medical history of breast cancer, breast
biopsy, or cyst aspiration. Of the 2,137 eligible Hispanic/Latino women who we identified, 1,591 (74.5%)
provided baseline interviews. Of the women who we were able to contact after the initial enrollment, our
participation rate was 92%. Study subjects were limited to the 1,569 (98.6%) who provided signed
consent to review radiology records. Mammographic data were available for 1,040 study participants who
received at least one screening mammogram during the follow-up study period. Because state law
mandates that breast density is recorded and shared with patients, 100% of screening mammogram reports
included density information. For women who received more than one screening mammogram, breast
density was recorded for each exam report retrieved.
Measures and Definitions
Dependent Variable
Based on the BI-RADS classification system, breast density, as listed on screening
mammograms, was categorized as fatty, scattered fibroglandular densities, heterogeneously dense, and
extremely dense. For most analyses, a dichotomized breast density variable (dense versus nondense) was
3

utilized. Women reported as having extremely or heterogeneously dense breasts were categorized as
“dense”, while women in the fatty or scattered density categories were classified as “nondense”. For
participants for whom multiple reports were retrieved during follow-up, changes in breast density
measures across tests and over time were anticipated. Previous studies show that density tends to decrease
over time (i.e. with age) (22, 23). As a result, we relied on the assumption that density would not increase
over the follow up period. Discrepancies in BI-RADS reported density over time may have been a result
of variation in radiologist interpretation of the mammographic images. For our purposes, if earlier reports
indicated a woman had nondense breasts, and a single later report indicated dense breasts, the participant
was categorized as “nondense” as it is more likely and biologically plausible that density would decrease
over time, not increase. As expected, some women transitioned from having dense breasts to less dense
breasts over time (with age). Thus, women whose earlier mammograms were classified as dense and later
transitioned to nondense were considered dense for the purpose of our analysis.
Independent Variables
Baseline characteristics
Baseline sociodemographic variables included age (<50, ≥50 years old), marital status (single,
married/partnered), education level (less than high school, some college or more), income
(<$10,000/year, $10,000-14,999, ≥$15,000), and employment status (yes, no). Access to care variables
were insurance status (none, public only, other coverage), usual care provider (yes, no), self-rated health
(fair/poor, good/very good), and mammogram in the last year (yes, no). Acculturation variables included
number of years lived in the United States (U.S. born, <10 years in U.S., ≥10 years in U.S.), self-rated
spoken English (no English/not well, very well), and country of origin (U.S. born, foreign born, Puerto
Rican born).
Reproductive and Physiological Variables
Women who reported having completed menopause (no menses for previous 12 months) or
whose periods had ceased due to hormone replacement therapy, hysterectomy, or oophorectomy were
categorized as postmenopausal. Those who had a period in the previous 12 months were categorized as
premenopausal. Women who reported that they were in the process of going through menopause were
4

categorized as perimenopausal. Women were also classified (yes, no) based on hormone replacement
therapy use, hysterectomy/oophorectomy status, regular exercise (at least one time per week), diabetes
status (ever been told by a doctor that they had diabetes; of note, 94% of women who self-reported
diabetes diagnosis also reported insulin use and/or oral medication), history of infertility (trying for one
year or more without getting pregnant), family history of breast cancer (among primary relatives), and
alcohol consumption in the last year. BMI categories (normal/underweight, obese, and overweight) were
created from continuous, height and weight data. Although these data were self-reported by participants,
in general the information was read from a card that was filled out at the time of the primary care
appointment and reflected current, measured height and weight at the time of the appointment. The mean
number of live births in this sample was 4 births, and as such, parity was categorized as nulliparous, <4,
and ≥4 live births. Age at first birth was also collected as a continuous variable (mean age being 19 years
old) and later stratified into three groups, nulliparous, <19, and, ≥19. Breastfeeding was assessed through
the cumulative number of months that a woman breastfed. The strata included never breastfed, <12
months, and ≥12 months. Women with no children were included in the “never breastfed” strata.
Additional variables in the analysis were consumption of traditional Hispanic/Latino diet (less than
weekly, 1-3 times per week, 4-6 times per week, everyday), sum of comorbidities (0-1, 2,3,>3), bra size
(A, B, C, D, DD or larger), and oral contraceptive use (never used, ≤4 years, >4 years).
Statistical Analysis
Bivariate analyses were conducted using chi square, for which p-values were reported, and
logistic regression. Baseline characteristics were adjusted for age while reproductive and physiological
variables were adjusted for age and BMI. Total number of comorbidities and diabetes were adjusted with
age, a continuous variable for BMI, and bra size, in order to control for residual confounding.
Multivariate logistic regression was performed to calculate odds ratios and 95% confidence intervals to
determine associations between significant baseline characteristics and all reproductive and physiological
factors and breast density. We used stepwise elimination and set significance levels for which variables
entered and exited the model to 0.1 and 0.15 respectively. Additionally, education was forced into this
5

multivariate model in order to control for socioeconomic factors that were not included in the analysis.
Possible interactions with age and BMI were tested among significant variables using stratified analyses
and the Breslow-Day test for homogeneity. For these analyses, BMI was dichotomized
(normal/underweight, obese/overweight). A categorical variable for age at menarche was created based on
the average age at menarche reported by women in the cohort (>12, ≤12 years old). Interaction terms were
also tested in the multivariate model. All analyses and data management were conducted using SAS
version 9.4.

Results
Of the women who received screening mammograms during the follow-up period (n=1,040),
16.4% were reported as having fatty breasts, 56.6% with scattered fibroglandular densities, 25% with
heterogeneously dense breasts, and 2% with extremely dense breasts (Table 1, Figure 1). With
categorization of the breast density variable into “dense” and “nondense”, we report that 280 (27%) had
dense breasts and 760 (73%) had nondense breasts.
Table 1: Distribution of BI-RADS breast density in Hispanic/Latino women in Connecticut (n=1,040)
BI-RADS Category
Frequency
%
Fatty (0 - <25%)a
171
16.4
Scattered with fibroglandular densities
(25-50%)
Heterogeneous (51-75%)

589

56.6

260

25.0

Extremely (>75%)

20

2.0

a

Percentage of breast density.
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Percentage of Cohort
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Descriptive data by breast density are shown in Table 2. The distribution of breast density in the
cohort differed significantly by age group, marital status, income, employment, insurance status, whether
or not a mammogram was received in the last year, and by country of origin. Women younger than 50
years old were more likely to have dense breasts relative to women aged 50 years or older. Participants
who reported being unemployed, single, receiving public insurance, having a mammogram in the last
year, and earning a low income (particularly women who earned less than $10,000 per year) were found
to be at significantly reduced odds of having dense breasts. Women born outside the continental United
States but living in the United States for over ten years were at 1.59 times the odds of having dense
breasts relative to women who were born within the United States. Women born outside the continental
United States but living in the United States for less than 10 years were also at 1.59 times the odds of
having dense breasts however this association was not significant. Puerto Rican born (OR = 1.33, 95% CI
0.87 – 2.04) and foreign born (OR = 2.11 95% CI 1.34 – 3.31) participants were at increased odds of
density relative to those born in the United States. Once adjusted for age, marital status, income, and
insurance status were not significantly associated with density. After adjusting for age, breast density was
still significantly lower among women who received a mammogram in the last year and women who were
unemployed. Women living in the United States for over 10 years were at significantly increased odds of
having dense breasts adjusting for age (OR = 1.96, 95% CI, 1.28 – 3.00) while living in the United States
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for less than 10 years showed only a marginally significant association with breast density (OR = 1.74,
95% CI, 1.00 – 3.02). Foreign born women were at 2.32 (95% CI 1.46 – 3.69) times the odds of having
dense breasts, while women born in Puerto Rico were at 1.68 (95% CI 1.08 – 2.60) times the odds of
dense breasts compared to women born in the United States. No significant associations were found
between density and English language skill, self-rated health, having a usual care provider, and level of
education.
Table 2: Descriptive characteristics of cohort by breast density
Characteristic

Sociodemographic
Age (years)
<50
≥50
Marital status
Single
Married/Partnered
Education Level
<12 years
≥12 years
Income
<$10, 000
$10,000-$14,999
$15,000+
Employment
No
Yes
Access to Care
Insurance Status
None
Public only
Other Coverage
Usual Care Provider
No
Yes
Self-rated Health
Fair/Poor
Good/Excellent
Mammogram in Last Year
No
Yes
Acculturation
Acculturation
≥10 years in U.S.
<10 years in U.S.
U.S. Born

n (%)a

Denseb
Breasts
(n = 280 )

Non-Dense
Breasts
(n = 760)

OR (95% CI)

p-valuec

Age Adjusted
OR (95%CI)

443 (42.6)
597 (57.4)

171 (61.1)
109 (38.9)

272 (35.8)
488 (64.2)

2.81 (2.12 – 3.73)
1.00

<.0001

--

686 (66.0)
354 (34.0)

166 (59.3)
114 (40.7)

520 (68.4)
240 (31.6)

0.67 (0.51 – 0.89)
1.00

0.0058

0.77 (0.58 – 1.03)
1.00

568 (54.8)
468 (45.2)

143 (51.2)
136 (48.8)

425 (56.1)
332 (43.9)

0.82 (0.62 – 1.08)
1.00

0.1608

1.01 (0.76 – 1.35)
1.00

495 (50.2)
247 (25.0)
245 (24.8)

115 (43.1)
67 (25.1)
85 (31.8)

380 (52.8)
180 (25.0)
160 (22.2)

0.57 (0.41 – 0.80)
0.70 (0.48 – 1.03)
1.00

0.0043d

0.73 (0.52 – 1.05)
0.78 (0.52 – 1.15)
1.00

762 (73.3)
278 (26.7)

177 (63.2)
103 (36.8)

585 (77.0)
175 (23.0)

0.51 (0.38 – 0.69)
1.00

<0.0001

0.63 (0.47 – 0.86)
1.00

169 (16.3)
764 (73.6)
105 (10.2)

59 (21.1)
185 (66.0)
36 (12.9)

110 (14.5)
579 (76.4)
69 (9.1)

1.03 (0.62 – 1.72)
0.61 (0.40 – 0.95)
1.00

0.0037

1.03 (0.61 – 1.74)
0.64 (0.41 – 1.00)
1.00

487 (47.1)
546 (52.9)

134 (48.0)
145 (52.0)

353 (46.8)
401 (53.2)

1.05 (0.79 – 1.38)
1.00

0.7290

1.05 (0.80 – 1.39)
1.00

570 (56.4)
440 (43.6)

151 (55.5)
121 (44.5)

419 (56.8)
319 (43.2)

0.95 (0.72 – 1.26)
1.00

0.7201

0.93 (0.70 – 1.24)
1.00

336 (32.5)
697 (67.5)

77 (27.7)
201 (72.3)

259 (34.3)
496 (65.7)

0.73 (0.54 – 0.99)
1.00

0.0444

0.67 (0.49 – 0.91)
1.00

736 (71.4)
130 (12.6)
165 (16.0)

209 (74.9)
37 (13.3)
33 (11.8)

527 (70.1)
93 (12.4)
132 (17.5)

1.59 (1.05 – 2.40)
1.59 (0.93 – 2.73)
1.00

0.0836

1.96 (1.28 – 3.00)
1.74 (1.00 – 3.02)
1.00
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Self-rated Spoken English
None/not well
Very well
Country of Origin
Puerto Rico
Foreign born
US Born
a

784 (86.9)
118 (13.1)

215 (84.3)
40 (15.7)

569 (87.9)
78 (12.1)

0.74 (0.49 – 1.11)
1.00

0.1453

1.01 (0.66 – 1.55)
1.00

584 (56.2)
290 (27.9)
165 (15.9)

146 (52.3)
100 (35.9)
33 (11.8)

438 (57.6)
190 (25.0)
132 (17.4)

1.33 (0.87 -2.04)
2.11 (1.34 – 3.31)
1.00

0.0011d

1.68 (1.08 – 2.60)
2.32 (1.46 – 3.69)
1.00

As a result of missing data, numbers may not sum to totals.
Dense defined as having heterogeneously or extremely dense breasts according to BI-RADS (>50% dense).
c
p-values from chi-square tests.
d
Significant trend p-value.
b

Reproductive and physiological variables are listed in Table 3 by breast density. Perimenopausal
(OR = 1.89, 95% CI 1.06 – 3.36) and premenopausal women (OR = 3.04, 95% CI 2.23 – 4.08) were at
significantly increased odds of having dense breasts relative to postmenopausal women. After adjusting
for age and BMI, only premenopausal status was significantly associated with density. Relative to
nulliparous women, women with higher parity (≥4 births) had reduced odds while women with lower
parity (<4 births) were at increased odds of having dense breasts. In the unadjusted and adjusted bivariate
models, the effect of parity was not significant. Hormone replacement therapy and receipt of a bilateral
oophorectomy were significantly inversely associated with having dense breasts. Women who reported
having a history of infertility were at significantly higher odds of having dense breasts relative to women
with no history of infertility. Adjusting for age and BMI, neither hormone replacement therapy,
oophorectomy status, nor history of infertility were associated with density. We observed a significant
trend in increasing number of comorbidities and increased bra size with lower breast density (p<0.0001).
Higher BMI and having diabetes were also significantly protective (p<0.0001). After adjustment, diabetes
and increasing bra size remained protective while total number of comorbidities was no longer associated
with density. Age at menarche, oral contraceptive use, age at first birth, duration of breastfeeding, family
history of breast cancer, exercise, alcohol use, and consuming a traditional Hispanic or Latino diet were
additionally not found to be significantly predictive of breast density.
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Table 3: Bivariate associations of reproductive and physiological variables with breast density
Characteristic

n (%)

Age at Menarche
(Mean, SD)
Menopause Statusa
Perimenopausal
Premenopausal
Postmenopausal
HRT Used
Yes
No
Oral Contraceptive
Use
>4 years
≤4 years
Never used
Oophorectomy
Yes
No
Parity
≥4
<4
Nulliparous
Age at first birth
≥19
<19
Nulliparous
Months of
Breastfeeding
≥12 months
<12 months
Never
History of Infertility
Yes
No
Family History of
Breast cancer
Yes
No
BMI
Overweight
Obese

12.4 (2.03)

Normal/underweight

Sum of
comorbiditiesf
>3
3
2
0-1
Diabeticf
Yes
No

Dense
Breasts
(n = 280 )

OR (95% CI)

p-valueb

Adjusted ORc

pvaluec

1.02 (0.96 – 1.09)

0.5400

1.00 (0.93 – 1.08)

0.9861

NonDense
Breasts
(n = 760)

63 (6.2)
344 (33.6)
618 (60.3)

19
141
115

44
203
503

1.89 (1.06 – 3.36)
3.04 (2.23 – 4.08)
1.00

<.0001e

1.37 (0.73 – 2.58)
1.66 (1.10 – 2.51)
1.00

0.0519

120 (11.8)
899 (88.2)

22
251

98
648

0.58 (0.36 – 0.94)
1.00

0.0259

0.77 (0.46 – 1.30)
1.00

0.3336

147 (14.5)
442 (43.7)
423 (41.8)

32
119
114

112
323
309

0.85 (0.55 – 1.31)
0.99 (0.74 – 1.35)
1.00

0.7298

0.77 (0.48 – 1.24)
0.86 (0.61 – 1.19)
1.00

0.4774

146 (14.4)
868 (85.6)

29
243

117
625

0.64 (0.41 – 0.98)
1.00

0.0416

0.86 (0.53 – 1.39)
1.00

0.5405

419 (40.8)
582 (56.7)
25 (2.5)

76
191
8

343
391
17

0.47 (0.20 – 1.13)
1.04 (0.44 – 2.45)
1.00

<0.0001e

0.49 (0.19 – 1.29)
0.96 (0.37 – 2.46)
1.00

0.0004

544 (53.1)
448 (43.7)
33 (3.2)

178
86
11

366
362
22

0.97 (0.46 – 2.05)
0.48 (0.22 – 1.02)
1.00

<0.0001e

1.00 (0.44 – 2.23)
0.54 (0.24 – 1.22)
1.00

0.0007

274 (27.2)
289 (28.6)
446 (44.2)

78
75
117

196
214
329

1.12 (0.80 – 1.57)
0.99 (0.70 – 1.38)
1.00

0.7533

1.00 (0.69 – 1.45)
0.91 (0.36 – 1.31)
1.00

0.8598

140 (13.7)
884 (86.3)

52
222

88
662

1.76 (1.21 – 2.57)
1.00

0.0031

1.32 (0.87 – 1.98)
1.00

0.1881

110 (12.2)
795 (87.9)

25
228

85
567

0.73 (0.46 – 1.17)
1.00

0.1938

0.89 (0.54 – 1.49)

0.6627

308 (31.0)
551 (55.5)
134 (13.5)

102
94
69

206
457
65

0.47 (0.31 – 0.71)
0.19 (0.13 – 0.29)
1.00

<0.0001e

--

--

290 (28.8)
182 (18.1)
210 (20.9)
324 (32.2)

45
47
60
120

245
135
150
204

0.32 (0.21 – 0.46)
0.59 (0.40 – 0.88)
0.68 (0.47 – 0.99)
1.00

<0.0001e

0.59 (0.38 – 0.90)f
0.71 (0.45 – 1.11)
0.76 (0.50 – 1.14)
1.00

0.0917 f

522 (33.8)
1023 (66.2)

58
213

297
435

0.40 (0.29 – 0.55)
1.00

<0.0001

0.62 (0.43 – 0.90)f
1.00

0.0113 f
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a

Bra Size
DD or larger
D
C
B
A
Exercise Once per
week
Yes
No
Traditional
Hispanic/Latino
Diet
Everyday
4-6 times/week
1-3 times/week
Less than weekly
Alcohol
Consumption
Yes
No

53 (5.2)
223 (22.0)
343 (3.8)
350 (34.5)
45 (4.4)

6
47
87
110
24

47
176
256
240
21

0.11 (0.40 – 0.31)
0.23 (0.12 – 0.46)
0.30 (0.16 – 0.56)
0.40 (0.21 – 0.75)
1.00

<0.0001e

0.21 (0.22 – 0.41)
0.36 (0.17 – 0.74)
0.42 (0.21 – 0.85)
0.49 (0.25 – 0.99)
1.00

0.0267

430 (44.4)
538 (55.6)

122
143

308
395

1.09 (0.82 – 1.45)
1.00

0.5344

1.05 (0.77 – 1.43)
1.00

0.7623

549 (61.9)
129 (14.6)
181 (20.4)
27 (3.1)

162
42
39
5

387
87
142
22

1.84 (0.67 – 4.95)
2.12 (0.75 – 6.00)
1.21 (0.43 – 3.40)
1.00

0.0754e

1.12 (0.39 – 3.25)
1.28 (0.42 – 3.93)
0.78 (0.26 -2.38)
1.00

0.3215

230 (24.0)
727 (76.0)

68
195

162
532

1.15 (0.83 – 1.59)
1.00

0.4169

0.95 (0.67 – 1.37)
1.00

0.8059

Postmenopausal group includes women with induced menopause.
p-values from chi-square tests.
c
Adjusted for BMI and age.
d
HRT, hormone replacement therapy.
e
Significant trend p-value.
f
Adjusted with age, continuous BMI variable, and bra size.
b

Adjusting for education, history of infertility, receipt of a mammogram in the last year, bra cup
size, and parity, breast density was significantly associated with age at menarche, age, premenopausal
status, diabetes, and BMI (Table 4). We observed a strong negative association between density, age, and
BMI. Compared to women of normal weight, overweight and obese women were less likely to have dense
breasts. Additionally, women over the age of 50 years old were at significantly reduced odds of dense
breasts relative to women younger than 50 years old (OR = 0.48, 95% CI 0.30 – 0.78). We also observed
an inverse relationship between age at menarche and breast density (OR = 0.89, 95% CI 0.81 – 0.98). In
our multivariate model, premenopausal women were at 1.82 times the odds of having dense breasts (95%
CI 1.13 – 2.92) compared to women who were postmenopausal. Perimenopausal women were also at
increased odds of density (OR = 1.36, 95% CI 0.65 – 2.83), however this association was not significant.
Interestingly, the protective effect of diabetes persisted in the multivariate model. Our findings showed
that women with diabetes had significantly reduced odds of dense breasts relative to women without
diabetes (OR=0.62, 95% CI 0.41 – 0.90). Although having children before or after the age of 19 years old
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appeared protective from breast density compared to being nulliparous, these associations were not
statistically significant.
Table 4: Multivariate associations of participant characteristics with breast densitya
Characteristic
OR
95% CI
Age at Menarche
Age
≥50
<50
Age at first birth
≥19
<19
Nulliparous
Menopause Status
Premenopausal
Perimenopausal
Postmenopausal
Diabetes
Yes
No
BMI
Overweight
Obese
Normal/underweight

0.89

0.81 – 0.98

0.48
1.00

0.30 – 0.78
--

0.46
0.29
1.00

0.06 – 3.42
0.04 – 2.18
--

1.82
1.36
1.00

1.13 – 2.92
0.65 – 2.83
--

0.62
1.00

0.41 – 0.95
--

0.53
0.23
1.00

0.31 – 0.90
0.13 – 0.38
--

a

Adjusted for education, history of infertility, receipt of mammogram in the last year, bra cup size, and parity.

We tested for interactions between age, BMI, and significant variables in the multivariate model.
There was evidence of an interaction between age at menarche and BMI (Table 5, Figure 2). Normal and
underweight women who experienced menarche before the age of 12, were at 1.92 times the odds of
having dense breasts relative to women who experienced menarche after age 12. Conversely, obese and
overweight women who experienced menarche earlier were at reduced odds of dense breasts relative to
obese and overweight women who began menstruating at an older age. We analyzed this interaction term
within the final multivariate model, however, adding the term worsened the overall model fit.
Consequently, we reported the results from the stratified analysis and Breslow-Day test for homogeneity
(p-value = 0.049).
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Table 5: Results from stratified analysis of age at menarche and breast density by BMI
BMI Category

OR

95% CI

Normal/Underweight

1.93

0.97 - 3.84

Overweight/Obese

0.9

0.65 - 1.24

Common

1.03

0.77 - 1.38

p-valuea

0.049

a

p-value from Breslow-Day test for homogeneity.

Figure 2: Interac.ons Between Age at Menarche and BMI,
Breslow-Day Test for Homogeneity

Normal/
Underweight
Obese/Overweight
Common OR

0

0.5

1

1.5

2

2.5

3

3.5

4

Odds RaMo and 95% Wald Conﬁdence Limits

Discussion
In this study we aimed to identify predictors of breast density, an important risk factor for breast
cancer, in Hispanic and Latino women living in Connecticut. Unlike other studies in which cross sectional
study designs were utilized to examine breast density in Hispanic and Latino women, we followed
participants prospectively in order to uncover potential factors that give rise to density. Additionally, this
study focused primarily on women living in the Northeast region of the United States. Considering the
limited data on this particular population, we comprehensively examined a number of breast cancer risk
factors, known predictors of breast density, and sociodemographic variables. Our multivariate analyses
showed associations of breast density with age, BMI, age at menarche, diabetes, and premenopausal
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status adjusting for education, history of infertility, receipt of mammogram in the last year, bra cup size,
and parity. We also observed a potential interaction between age at menarche and BMI.
Breast density predictors in Hispanic and Latino women identified in this study including age,
BMI, menopause status, and age at menarche are consistent with previously reported studies (14, 22-24).
Although risk factors across populations appear comparable, we note that the overall distribution of breast
density among our study population differs from that of the general population. Our results showed that of
women for whom density data were collected, only 25% had dense breasts (2% extremely dense and 25%
heterogeneously dense). The American College of Radiology, however, report that in the general
population, 50% of women have dense breasts (10% extremely and 40% heterogeneous) (25). This
variation in breast density distribution may, in part, explain lower breast cancer incidence among
Hispanic and Latino women compared to White and Black women. Further investigation is required to
understand contributing factors to these distributional differences and determine if lower breast density is
a potential driver of reduced breast cancer risk in this population.
Despite its association with increased breast cancer risk, BMI is significantly inversely associated
with dense breasts (12, 14, 26). Obese and overweight women have a lower ratio of dense to fatty tissue
in the breast relative to normal weight women (26). Studies indicate that fatty breasts may be protective
against breast cancer, possibly as a result of fewer epithelial and stromal cells in the breast that could give
rise to cancerous tumors (5, 9). Obese and overweight women may also have larger breasts relative to
women of normal weight. We’ve shown that increasing bra size is associated with decreased odds of
dense breasts and studies suggest that the effect of density on breast cancer risk is lower among women
with larger breasts relative to women with smaller breasts (27). Controlling for bra size however, we’ve
shown an independent protective effect of higher BMI on breast density. BMI and breast size may be
related, but they appear to operate independently of one another as predictors of breast density.
Our findings also suggest an interaction between age at menarche and BMI. Among normal
weight women, experiencing menarche before the age of 12 is associated with a two fold increase in the
odds of having dense breasts relative to women who began menses over the age of 12. Among obese
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women however, the effect of early age at menarche is truncated by the effect of obesity. These women
are protected against dense breasts even if they experience menarche earlier. This finding has implications
for the relative importance of each of these breast density predictors as it appears the effect of BMI is
stronger than that of age at menarche.
Among other variables included in the analysis is diabetes, which is suggested to be a weak risk
factor for breast cancer, although the biological mechanism of disease has yet to be identified (28-30). In
contrast, in our population, diabetes was associated with a decrease in odds of dense breasts. Previous
studies examining the relationship between diabetes and breast density yielded conflicting results. Among
Native American women, diabetes was similarly shown to have a negative relationship with dense
breasts, however this was only significant among premenopausal women (31). Other studies report no
association between density and diabetes (28, 32). Discrepancies between studies could be a result of
differences in outcome classification (categorized versus quantitative measures of breast density) or
ethnic differences among study populations (28, 32). Of the women in our study population who were
diabetic, 94% reported taking insulin, other oral medication, or both. The use of diabetes medication may
explain the relationship we observed in our investigation. Studies are currently underway to examine the
effect of the diabetes medication, metformin, on breast density (33).
Strengths of this investigation include the use of a prospective cohort study design. In using this
design we may establish temporality between significant predictors and breast density. Additionally, the
baseline questionnaire allowed for the collection of a comprehensive set of variables for the study
including sociodemographic, reproductive, and physiological data (as well information on potential
confounders) on the cohort. One limitation of our study involves the subjective assessment of breast
density. We ascertained our outcome from mammography reports retrieved from screening facilities
throughout Connecticut. The BI-RADS categorization listed on the report provided the radiologists’
classification of density, which we used to further categorize our cohort as “dense” and “nondense”. BIRADS is a qualitative method used in determining breast density and reporting is not protected against
potential bias or variation in radiologist reporting. Automated quantitation may assist in obtaining
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accurate and objective measurements of breast density in future studies (34). Another limitation to the
study involves changes in breast density over time. We collected mammography reports from screening
facilities throughout the follow-up period. Breast density has been shown to decline over time (i.e. with
age) and we generally assumed breast density would not increase over the follow-up period (22, 23). As
such, if a woman was reported as having nondense breasts earlier in follow-up but was later reported to be
dense (based on reports received later in follow-up), she was categorized as having nondense breasts.
While such changes in density categorization were likely a result of variation in radiologist reporting, this
impacted very few women in our study (n=11).
This study provided an opportunity to examine breast density in the population of Hispanic and
Latino women living in the Northeast region of the United States. Additionally, this investigation gives
insight to a population in which prevalence of diabetes and comorbidity is high relative to the overall
population of the United States (35). Breast density predictors in our cohort are consistent with predictors
in the general population. We report, however, that the distribution of density in our cohort differs from
that of the general population and may explain lower breast cancer risk among Hispanic and Latino
women. We also found a significant inverse association between density and diabetes. Although there is
some discrepancy among previous findings, this may be a unique phenomenon among this population that
elicits further study along with the potential impact of diabetes medication use on density. Our results also
suggest that the effect of age at menarche may be modified by BMI. In describing the breast density
distribution in Hispanic and Latino women and identifying risk factors in this population, these findings
not only add to the body of breast density literature but also promote our understanding of density in this
understudied population and provide evidential basis for future breast density research.

16

References
1.
Ban KA, Godellas CV. Epidemiology of breast cancer. Surgical oncology clinics of North America.
2014;23:409-22.
2.
Breast Cancer Facts & Figures. 2015 [cited 2016 April 1]; Available from:
http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-046381.pdf
3.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: a cancer journal for clinicians.
2016;66:7-30.
4.
Cancer Facts & Figures for Hispanic/Latinos 2015-2017. 2015 [cited 2015 March 15]; Available
from: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-046405.pdf
5.
McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of
breast cancer risk: a meta-analysis. Cancer epidemiology, biomarkers & prevention : a publication of the
American Association for Cancer Research, cosponsored by the American Society of Preventive
Oncology. 2006;15:1159-69.
6.
Boyd NF, Lockwood GA, Martin LJ, Knight JA, Byng JW, Yaffe MJ, et al. Mammographic densities
and breast cancer risk. Breast disease. 1998;10:113-26.
7.
Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of
mammographic densities and breast cancer risk: results from the Canadian National Breast Screening
Study. Journal of the National Cancer Institute. 1995;87:670-5.
8.
Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, et al. Mammographic breast
density and subsequent risk of breast cancer in postmenopausal women according to tumor
characteristics. Journal of the National Cancer Institute. 2011;103:1179-89.
9.
Shepherd JA, Kerlikowske K. Do fatty breasts increase or decrease breast cancer risk? Breast
cancer research : BCR. 2012;14:102.
10.
Pettersson A, Hankinson SE, Willett WC, Lagiou P, Trichopoulos D, Tamimi RM. Nondense
mammographic area and risk of breast cancer. Breast cancer research : BCR. 2011;13:R100.
11.
ACR BI-RADS Atlas - Mammography. BI-RADS Mammography Reporting 2013 2013 [cited 2016
April 1]; Available from:
http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/BIRADS/01%20Mammogra
phy/02%20%20BIRADS%20Mammography%20Reporting.pdf
12.
Caire-Juvera G, Arendell LA, Maskarinec G, Thomson CA, Chen Z. Associations between
mammographic density and body composition in Hispanic and non-Hispanic white women by
menopause status. Menopause (New York, NY). 2008;15:319-25.
13.
del Carmen MG, Hughes KS, Halpern E, Rafferty E, Kopans D, Parisky YR, et al. Racial differences
in mammographic breast density. Cancer. 2003;98:590-6.
14.
Gapstur SM, Lopez P, Colangelo LA, Wolfman J, Van Horn L, Hendrick RE. Associations of breast
cancer risk factors with breast density in Hispanic women. Cancer epidemiology, biomarkers &
prevention : a publication of the American Association for Cancer Research, cosponsored by the
American Society of Preventive Oncology. 2003;12:1074-80.
15.
Thomson CA, Arendell LA, Bruhn RL, Maskarinec G, Lopez AM, Wright NC, et al. Pilot study of
dietary influences on mammographic density in pre- and postmenopausal Hispanic and non-Hispanic
white women. Menopause (New York, NY). 2007;14:243-50.
16.
Rice MS, Biessy C, Lajous M, Bertrand KA, Tamimi RM, Torres-Mejia G, et al. Metabolic
syndrome and mammographic density in Mexican women. Cancer prevention research. 2013;6:701-10.
17.
Calderon-Garciduenas AL, Sanabria-Mondragon M, Hernandez-Beltran L, Lopez-Amador N,
Cerda-Flores RM. Mammographic breast density patterns in asymptomatic mexican women. Radiology
research and practice. 2012;2012:127485.

17

18.
Rice MS, Bertrand KA, Lajous M, Tamimi RM, Torres G, Lopez-Ridaura R, et al. Reproductive and
lifestyle risk factors and mammographic density in Mexican women. Annals of epidemiology.
2015;25:868-73.
19.
Rice MS, Bertrand KA, Lajous M, Tamimi RM, Torres-Mejia G, Biessy C, et al. Body size
throughout the life course and mammographic density in Mexican women. Breast cancer research and
treatment. 2013;138:601-10.
20.
United States Census Bureau. Projections of the Size and Composition of the US Population:
2014 to 2060 2014 October 15, 2014 [cited 2015 April 1]; Available from:
https://www.census.gov/newsroom/facts-for-features/2014/cb14-ff22.html
21.
U.S. Census Bureau. 2014 [cited 2016 April 1]; Available from:
https://www.census.gov/newsroom/facts-for-features/2014/cb14-ff22.html
22.
Checka CM, Chun JE, Schnabel FR, Lee J, Toth H. The relationship of mammographic density and
age: implications for breast cancer screening. AJR American journal of roentgenology. 2012;198:W292-5.
23.
Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current
understanding and future prospects. Breast cancer research : BCR. 2011;13:223.
24.
Tehranifar P, Reynolds D, Flom J, Fulton L, Liao Y, Kudadjie-Gyamfi E, et al. Reproductive and
menstrual factors and mammographic density in African American, Caribbean, and white women.
Cancer causes & control : CCC. 2011;22:599-610.
25.
American College of Radiology. Breast Density Breast Cancer Screening 2012 [cited 2016 April
27]; Available from: http://www.acr.org/NewsPublications/~/media/180321AF51AF4EA38FEC091461F5B695.pdf
26.
Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, et al. Body size, mammographic density,
and breast cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American
Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
2006;15:2086-92.
27.
Stuedal A, Ma H, Bernstein L, Pike MC, Ursin G. Does breast size modify the association between
mammographic density and breast cancer risk? Cancer epidemiology, biomarkers & prevention : a
publication of the American Association for Cancer Research, cosponsored by the American Society of
Preventive Oncology. 2008;17:621-7.
28.
Sellers TA, Jensen LE, Vierkant RA, Fredericksen ZS, Brandt KR, Giuliano AR, et al. Association of
diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family
study. Cancer causes & control : CCC. 2007;18:505-15.
29.
Redaniel MT, Jeffreys M, May MT, Ben-Shlomo Y, Martin RM. Associations of type 2 diabetes
and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among
British women. Cancer causes & control : CCC. 2012;23:1785-95.
30.
Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current
evidence. The American journal of clinical nutrition. 2007;86:s823-35.
31.
Roubidoux MA, Kaur JS, Griffith KA, Sloan J, Wilson C, Novotny P, et al. Correlates of
mammogram density in southwestern Native-American women. Cancer epidemiology, biomarkers &
prevention : a publication of the American Association for Cancer Research, cosponsored by the
American Society of Preventive Oncology. 2003;12:552-8.
32.
Tehranifar P, Reynolds D, Fan X, Boden-Albala B, Engmann NJ, Flom JD, et al. Multiple metabolic
risk factors and mammographic breast density. Annals of epidemiology. 2014;24:479-83.
33.
Wood ME, Huong, Rui Qin, Le-Petross T. , Hwang, E Shelley , Ligibel, Jennifer A. , Mayer, Ingrid
A. , Marshall, James Roger , Goodwin, Pamela Jean Change in mammographic density with metformin
use: A companion study to NCIC study MA.32. ASCO Annual Meeting; 2013.
34.
Heine JJ, Carston MJ, Scott CG, Brandt KR, Wu FF, Pankratz VS, et al. An automated approach for
estimation of breast density. Cancer epidemiology, biomarkers & prevention : a publication of the
18

American Association for Cancer Research, cosponsored by the American Society of Preventive
Oncology. 2008;17:3090-7.
35.
Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of
Diabetes and Its Burden in the United States, 2014 [cited 2016 April 27]; Available from:
http://www.cdc.gov/diabetes/data/statistics/2014statisticsreport.html

19

